tirzepatide surmount 5 Presented at ECO 2025: In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, was superior to semaglutide in reducing body weight and waist circumference. Full trial Tirzepatide superior to Semaglutide- SURMOUNT-5
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9






















![Fog [Beta Edition] H26](https://cdn.shopify.com/s/files/1/0645/8920/1573/files/0a7e5a73-42ca-5758-8e9d-9e4650a6b70b.jpg?v=1755170362)



